Clinical trials: Acute Hepatitis A
Hepatitis E
Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.
The purpose of the study is to compare the efficacy, safety and recurrence rate of two therapeutic strategies with ribavirin in patients with chronic hepatitis E and severe acute hepatitis E: fixed duration of treatment for 12…
- Trial name
- NCT02558114
- Testing
- Ribavirin
- Where
- Spain
- Volunteers
- 5 people
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
Acute-on-chronic Hepatitis B Liver Failure
Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure
This study was to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure (ACHBLF) on an individual patient level using artificial neural network (ANN) system.
- Trial name
- NCT01826760
- Testing
- Using training and testing groups to construct ANN based on laboratory tests
- Where
- China
- Volunteers
- 583 people, healthy volunteers welcome
- Sponsor
- Wenzhou Medical University
Acute Hepatitis C, Human Immunodeficiency Virus
Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV
New and recently EMA/FDA approved direct acting antiviral (DAA) combination therapies cure 95% or more of the patients chronically infected with HCV genotype 1 and 4.
- Conditions
- Acute Hepatitis C, Human Immunodeficiency Virus, Hepatitis C
- Trial name
- DAHHS-2 (NCT02600325)
- Testing
- Grazoprevir/Elbasvir 100mg/50mg
- Where
- 9 sites in Belgium, Netherlands
- Volunteers
- 80 people
- Sponsor
- Erasmus Medical Center
Risk Factors and Frequency of Acute Idiopathic Hepatitis in Children at Assiut Children Hospital
Risk Factors and Frequency of Acute Idiopathic Hepatitis in Children at Assiut Children Hospital
1. Determine the predisposing factors of acute hepatitis caused by heptotropic and non-hepatotropic viruses in children attending Assiut Children Hospital . 2.
- Trial name
- NCT06454760
- Volunteers
- 50 people
- Sponsor
- Youssef Khalifa Fakher Botros
Cirrhosis, Acute Hepatitis
Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant Period
Liver transplantation (LT) is the only curative treatment option for patients with severe liver disease. Since 2007, the implementation of the MELD score in liver transplant allocation guidelines has led to a change in the…
- Conditions
- Cirrhosis, Acute Hepatitis, Liver, mHLA-DR
- Trial name
- PREDITH (NCT07647978)
- Testing
- blood sampling, Biocollection
- Where
- 3 sites in France
- Volunteers
- 279 people
- Sponsor
- Hospices Civils de Lyon
Fulminant Hepatic Failure
Steroids in Fulminant Hepatitis A in the Pediatric Age Group
Fulminant hepatic failure (FHF) in children is a potentially devastating disease. The mortality rate may reach 80-90% in the absence of liver transplantation.
- Trial name
- NCT02375867
- Testing
- prednisolone, methylprednisolone
- Where
- Egypt
- Volunteers
- 33 people
- Sponsor
- National Liver Institute, Egypt
Severe Alcoholic Hepatitis
Intensive Enteral Nutrition and Acute Alcoholic Hepatitis
To evaluate the effect of an intensive enteral nutrition (compared to clinical routine) in association with corticosteroïds in patients with severe acute alcoholic hepatitis.
- Trial name
- NCT01801332
- Testing
- intensive nutrition, usual meals
- Where
- 19 sites in Belgium, France
- Volunteers
- 136 people
- Sponsor
- Erasme University Hospital
Chronic Hepatitis B
Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation
This is a prospective, observational, open-label, 2-arm, parallel, multi-center study. Patients with HBV-associated severe acute exacerbation for whom the treatment with NRTI (such as lamivudine and entecavir) is medically…
- Trial name
- NUC115132 (NCT01627223)
- Testing
- Lamivudine, Entecavir
- Where
- 8 sites in Taiwan
- Volunteers
- 17 people
- Sponsor
- Taichung Veterans General Hospital